SAM
MDGL icon

Simplify Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Simplify Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,302
Closed -$5.4M – 97
2025
Q1 		$5.4M Sell
16,302
-7,000
-30% -$2.3M 0.2% 24
2024
Q4 		$7.19M Sell
23,302
-3
-0% -$844 0.36% 17
2024
Q3 		$4.95M Sell
23,305
-8
-0% -$2.05K 0.23% 35
2024
Q2 		$6.53M Buy
23,313
+19
+0.1% +$4.52K 0.44% 22
2024
Q1 		$6.22M Buy
23,294
+9,000
+63% +$2.12M 0.37% 24
2023
Q4 		$3.31M Hold
14,294
– – 0.3% 26
2023
Q3 		$2.09M Hold
14,294
– – 0.24% 55
2023
Q2 		$3.3M Hold
14,294
– – 0.43% 22
2023
Q1 		$3.46M Buy
+14,294
New +$3.89M 0.5% 22

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplify Asset Management's MDGL Position: Q2 2025 in Review

Simplify Asset Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2025, closing a stake of 16,302 shares — an estimated $5.4M sold.

Simplify Asset Management first reported a position in MDGL in Q1 2023 and held it in 9 quarters. The position peaked at $7.19M in Q4 2024. 305 funds tracked by Wall St. Rank hold MDGL as of Q2 2025.

  • Simplify Asset Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplify Asset Management sold 16,302 Madrigal Pharmaceuticals shares in Q2 2025, an estimated $5.4M.
  • Simplify Asset Management first reported a position in Madrigal Pharmaceuticals in Q1 2023 and held it in 9 quarters.
  • Simplify Asset Management's Madrigal Pharmaceuticals position peaked at $7.19M in Q4 2024.
  • 305 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2025.

Based on Simplify Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.